Details for 2017775388
Up to date per 03.04.2026
Actions
Details for 2017775388
Deleted
European Patent
06.02.2019 A
22.09.2021 B1
31.03.2016
JP
2016071408
A61K 31/575 20060101AFI20191028BHEP
Owner
Intercept Pharmaceuticals, Inc.10 Hudson Yards, 37th Floor New York, NY 10001US
Representative
No representatives present
Inventor
MATONO, Mitsuhiroc/o Sumitomo Dainippon Pharma Co., Ltd. 3-45 Kurakakiuchi 1-chome Ibaraki-shi Osaka 567-0878JP
HAYAMA, Tetsuyac/o Sumitomo Dainippon Pharma Co., Ltd. Kobe KIMEC Center Building 5F 5-2 Minatojimaminamimachi 1-chome Chuo-ku Kobe-shi Hyogo 650-0047JP